ResFinder 4.0 for predictions of phenotypes from genotypes
Clicks: 22
ID: 290389
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
6.3
/100
22 views
4 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #47 of 82 articles by views in The Journal of antimicrobial chemotherapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objectives: WGS-based antimicrobial susceptibility testing (AST) is as reliable as phenotypic AST for several antimicrobial/bacterial species combinations. However, routine use of WGS-based AST is hindered by the need for bioinformatics skills and knowledge of antimicrobial resistance (AMR) determinants to operate the vast majority of tools developed to date. By leveraging on ResFinder and PointFinder, two freely accessible tools that can also assist users without bioinformatics skills, we aimed at increasing their speed and providing an easily interpretable antibiogram as output. Methods: The ResFinder code was re-written to process raw reads and use Kmer-based alignment. The existing ResFinder and PointFinder databases were revised and expanded. Additional databases were developed including a genotype-to-phenotype key associating each AMR determinant with a phenotype at the antimicrobial compound level, and species-specific panels for in silico antibiograms. ResFinder 4.0 was validated using Escherichia coli (n = 584), Salmonella spp. (n = 1081), Campylobacter jejuni (n = 239), Enterococcus faecium (n = 106), Enterococcus faecalis (n = 50) and Staphylococcus aureus (n = 163) exhibiting different AST profiles, and from different human and animal sources and geographical origins. Results: Genotype-phenotype concordance was ≥95% for 46/51 and 25/32 of the antimicrobial/species combinations evaluated for Gram-negative and Gram-positive bacteria, respectively. When genotype-phenotype concordance was <95%, discrepancies were mainly linked to criteria for interpretation of phenotypic tests and suboptimal sequence quality, and not to ResFinder 4.0 performance. Conclusions: WGS-based AST using ResFinder 4.0 provides in silico antibiograms as reliable as those obtained by phenotypic AST at least for the bacterial species/antimicrobial agents of major public health relevance considered.
| Reference Key |
openalex_W3048398081
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Valeria Bortolaia, Rolf Sommer Kaas, Étienne Ruppé, Marilyn C. Roberts, Štefan Schwarz, Vincent Cattoir, A. Philippon, Rosa Lundbye Allesøe, Ana Rita Rebelo, Alfred Ferrer Florensa, Linda Fagelhauer, Trinad Chakraborty, Bernd Neumann, Guido Werner, Jennifer K. Bender, Kerstin Stingl, Minh Ngoc Nguyen, Jasmine Coppens, Basil Britto Xavier, Surbhi Malhotra‐Kumar, Henrik Westh, Mette Pinholt, Muna F. Anjum, Nicholas Duggett, Isabelle Kempf, Suvi Nykäsenoja, Satu Olkkola, Kinga Wieczorek, Ana Amaro, Lurdes Clemente, Joël Mossong, Serge Losch, Catherine Ragimbeau, Ole Lund, Frank M. Aarestrup |
| Journal | The Journal of antimicrobial chemotherapy |
| Year | 2020 |
| DOI |
10.1093/jac/dkaa345
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.